{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-24-000047","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.427633+00:00","generated_at":"2026-06-04T04:26:54.606242+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"FDA clears Tandem Mobi insulin pump for pediatric use ages 2+","bullets":["FDA cleared Tandem Mobi insulin pump for expanded pediatric indication in individuals two years and older.","Clearance was granted via 510(k) application on March 21, 2024.","Indication expansion broadens Tandem's addressable patient population beyond prior adult-only use."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-24-000047","json":"https://secwatch.observer/filing/0001438133-24-000047.json","markdown":"https://secwatch.observer/filing/0001438133-24-000047.md","text":"https://secwatch.observer/filing/0001438133-24-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000047/0001438133-24-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000047/tndm-20240321.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:26:54.606242+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}